1	NEW	new	JJ	p2=NNP	2	nn	_
2	YORK	york	NNP	p2=NN	4	nn	_
3	(	(	-LRB-	_	4	punct	_
4	Reuters	reuters	NNP	_	8	nn	_
5	)	)	-RRB-	_	4	punct	_
6	-	-	:	p2=.	8	punct	_
7	Pfizer	pfizer	NNP	_	8	nn	_
8	Inc	inc	NNP	_	14	nsubj	14:A0=PAG
9	(	(	-LRB-	_	8	punct	_
10	PFE.N	pfe.n	NNP	_	8	appos	_
11	)	)	-RRB-	_	8	punct	_
12	may	may	MD	_	14	aux	14:AM-MOD
13	have	have	VB	_	14	aux	_
14	called	call	VBN	pb=call.01	0	root	_
15	its	its	PRP$	_	19	poss	_
16	$	$	$	_	18	quantmod	_
17	118	0	CD	_	18	number	_
18	billion	#crd#	CD	_	19	nn	_
19	bid	bid	NN	_	14	dobj	14:A1=PPT
20	for	for	IN	_	19	prep	_
21	AstraZeneca	astrazeneca	NNP	_	22	nn	_
22	Plc	plc	NNP	_	20	pobj	_
23	(	(	-LRB-	_	22	punct	_
24	AZN.L	azn.l	NNP	_	22	appos	_
25	)	)	-RRB-	_	22	punct	_
26	a	a	DT	_	30	det	_
27	"	"	``	_	30	punct	_
28	final	final	JJ	_	30	amod	_
29	"	"	''	_	30	punct	_
30	offer	offer	NN	p2=VBP	14	oprd	14:A2=PRD
31	,	,	,	_	14	punct	_
32	and	and	CC	_	14	cc	_
33	its	its	PRP$	_	35	poss	_
34	British	british	JJ	_	35	amod	_
35	rival	rival	NN	_	36	nsubj	36:A0
36	sees	see	VBZ	pb=see.01	14	conj	_
37	no	no	DT	_	38	det	_
38	prospect	prospect	NN	_	36	dobj	36:A1
39	of	of	IN	_	38	prep	_
40	a	a	DT	_	41	det	_
41	deal	deal	NN	_	39	pobj	43:A1=PPT
42	being	be	VBG	_	43	auxpass	_
43	revived	revive	VBN	pb=revive.01	41	partmod	_
44	.	.	.	_	36	punct	_

1	But	but	CC	_	4	cc	4:AM-DIS
2	Wall	wall	NNP	_	3	nn	_
3	Street	street	NNP	_	4	nsubj	8:A0=PAG;4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	n't	not	RB	_	4	neg	4:AM-NEG
6	ready	ready	JJ	_	4	acomp	4:A2=PRD
7	to	to	TO	_	8	aux	_
8	call	call	VB	pb=call.04	6	xcomp	_
9	in	in	IN	p2=RP	8	prep	8:C-V
10	the	the	DT	_	11	det	_
11	undertakers	undertaker	NNS	p2=NN	9	pobj	_
12	.	.	.	_	4	punct	_

1	"	"	``	_	13	punct	_
2	The	the	DT	_	3	det	_
3	deal	deal	NN	_	5	nsubjpass	5:A1=PPT
4	is	be	VBZ	_	5	auxpass	_
5	wounded	wound	VBN	pb=wound.01	13	ccomp	13:A1=PPT
6	,	,	,	_	5	punct	_
7	but	but	CC	_	5	cc	_
8	perhaps	perhaps	RB	_	10	advmod	_
9	not	not	RB	_	10	neg	_
10	dead	dead	JJ	_	5	conj	_
11	,	,	,	_	13	punct	_
12	"	"	''	_	13	punct	_
13	said	say	VBD	pb=say.01	0	root	_
14	Mark	mark	NNP	_	15	nn	_
15	Schoenebaum	schoenebaum	NNP	_	13	nsubj	13:A0
16	,	,	,	_	15	punct	_
17	an	an	DT	_	18	det	_
18	analyst	analyst	NN	_	15	appos	_
19	with	with	IN	_	18	prep	_
20	ISI	isi	NNP	_	21	nn	_
21	Group	group	NNP	_	19	pobj	_
22	in	in	IN	_	21	prep	_
23	New	new	NNP	_	24	nn	_
24	York	york	NNP	_	22	pobj	_
25	.	.	.	_	13	punct	_

1	Morningstar	morningstar	NN	p2=JJR	2	nn	_
2	analyst	analyst	NN	_	4	nn	_
3	Damien	damien	NNP	_	4	nn	_
4	Conover	conover	NNP	_	7	nsubj	7:A0
5	in	in	IN	_	4	prep	_
6	Chicago	chicago	NNP	_	5	pobj	_
7	said	say	VBD	pb=say.01	0	root	_
8	the	the	DT	_	9	det	_
9	odds	odds	NNS	_	15	nsubj	15:A1=PPT
10	of	of	IN	_	9	prep	_
11	an	an	DT	_	13	det	_
12	AstraZeneca	astrazeneca	NNP	_	13	nn	_
13	purchase	purchase	NN	_	10	pobj	_
14	had	have	VBD	_	15	aux	_
15	fallen	fall	VBN	pb=fall.01	7	ccomp	7:A1=PPT
16	well	well	RB	_	15	advmod	15:AM-MNR
17	below	below	IN	_	15	prep	15:A4=GOL
18	the	the	DT	_	21	det	_
19	50	0	CD	_	20	num	_
20	percent	percent	NN	_	21	nn	_
21	mark	mark	NN	_	17	pobj	_
22	.	.	.	_	7	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=JJ	2	nn	_
2	shareholders	shareholder	NNS	_	21	nsubj	21:A0=PAG
3	,	,	,	_	31	punct	_
4	some	some	DT	_	8	nsubj	8:A0=PAG
5	of	of	IN	_	4	prep	_
6	them	them	PRP	_	5	pobj	_
7	already	already	RB	_	8	advmod	8:AM-TMP
8	expressing	express	VBG	pb=express.01	2	rcmod	_
9	their	their	PRP$	_	10	poss	_
10	disappointment	disappointment	NN	_	8	dobj	8:A1=PPT
11	over	over	IN	_	10	prep	_
12	the	the	DT	_	13	det	_
13	company	company	NN	_	15	poss	_
14	's	's	POS	_	13	possessive	_
15	rebuff	rebuff	NN	_	11	pobj	_
16	of	of	IN	_	15	prep	_
17	Pfizer	pfizer	NNP	_	16	pobj	_
18	,	,	,	_	21	punct	_
19	may	may	MD	_	21	aux	21:AM-MOD
20	still	still	RB	_	21	advmod	21:AM-TMP
21	pressure	pressure	VB	pb=pressure.01	31	ccomp	31:A1=PPT
22	the	the	DT	_	23	det	_
23	board	board	NN	_	21	dobj	25:A0=PAG;21:A1=PPT
24	to	to	TO	_	25	aux	_
25	reconsider	reconsider	VB	pb=reconsider.01	21	xcomp	21:A2=PRD
26	,	,	,	_	31	punct	_
27	analysts	analyst	NNS	_	31	nsubj	31:A0
28	and	and	CC	_	27	cc	_
29	fund	fund	NN	_	30	nn	_
30	managers	manager	NNS	_	27	conj	_
31	said	say	VBD	pb=say.01	0	root	_
32	on	on	IN	_	31	prep	31:AM-TMP
33	Monday	monday	NNP	_	32	pobj	_
34	.	.	.	_	31	punct	_

1	That	that	DT	_	3	nsubj	3:A0=PAG
2	could	could	MD	_	3	aux	3:AM-MOD
3	force	force	VB	pb=force.01	0	root	_
4	the	the	DT	_	6	det	_
5	British	british	JJ	_	6	amod	_
6	company	company	NN	_	3	dobj	8:A0=PAG;3:A1=PPT
7	to	to	TO	_	8	aux	_
8	engage	engage	VB	pb=engage.01	3	xcomp	3:A2=PRD
9	with	with	IN	_	8	prep	8:A2=PPT
10	Pfizer	pfizer	NNP	_	9	pobj	_
11	,	,	,	_	10	punct	_
12	the	the	DT	_	15	det	_
13	largest	large	JJS	_	15	amod	_
14	U.S.	u.s.	NNP	_	15	nn	_
15	drugmaker	drugmaker	NN	p2=NNP	10	appos	_
16	.	.	.	_	3	punct	_

1	If	if	IN	_	3	mark	_
2	they	they	PRP	_	3	nsubj	3:A0=PAG
3	do	do	VBP	pb=do.02	8	advcl	8:AM-ADV
4	n't	not	RB	_	3	neg	3:AM-NEG
5	,	,	,	_	8	punct	_
6	Pfizer	pfizer	NNP	_	8	nsubj	8:A1=PPT
7	could	could	MD	_	8	aux	8:AM-MOD
8	come	come	VB	pb=come.01	0	root	_
9	back	back	RB	_	8	advmod	8:AM-DIR
10	with	with	IN	_	8	prep	8:A3=DIR
11	a	a	DT	_	13	det	_
12	new	new	JJ	_	13	amod	_
13	price	price	NN	_	10	pobj	_
14	in	in	IN	_	8	prep	8:AM-TMP
15	six	#crd#	CD	_	16	num	_
16	months	month	NNS	_	18	poss	_
17	'	'	POS	_	16	possessive	_
18	time	time	NN	_	14	pobj	_
19	as	as	IN	_	20	mark	_
20	prescribed	prescribe	VBN	pb=prescribe.01	8	advcl	8:AM-ADV
21	by	by	IN	_	20	agent	20:A0=PAG
22	UK	uk	NNP	_	24	nn	_
23	takeover	takeover	NN	_	24	nn	_
24	rules	rule	NNS	_	21	pobj	_
25	.	.	.	_	8	punct	_

1	"	"	``	_	4	punct	_
2	I	I	PRP	_	4	nsubj	6:A0=PAG
3	still	still	RB	_	4	advmod	4:AM-TMP
4	have	have	VBP	pb=have.02	15	ccomp	15:A1=PPT
5	to	to	TO	_	6	aux	_
6	believe	believe	VB	pb=believe.01	4	xcomp	_
7	this	this	DT	_	8	det	_
8	deal	deal	NN	_	9	nsubj	9:A1=PPT
9	is	be	VBZ	pb=be.01	6	ccomp	6:A1=PPT
10	far	far	RB	_	11	advmod	_
11	from	from	IN	_	9	prep	9:A2=PRD
12	dead	dead	JJ	_	11	amod	_
13	,	,	,	_	15	punct	_
14	"	"	''	_	15	punct	_
15	said	say	VBD	pb=say.01	0	root	_
16	Raghuram	raghuram	NNP	_	17	nn	_
17	Selvaraju	selvaraju	NNP	_	15	nsubj	15:A0;30:A0=PAG
18	,	,	,	_	17	punct	_
19	healthcare	healthcare	NN	p2=JJ	20	nn	_
20	equity	equity	NN	_	21	nn	_
21	research	research	NN	_	22	nn	_
22	analyst	analyst	NN	_	17	appos	_
23	with	with	IN	_	22	prep	_
24	Aegis	aegis	NNP	_	25	nn	_
25	Capital	capital	NNP	_	23	pobj	_
26	in	in	IN	_	25	prep	_
27	New	new	NNP	_	28	nn	_
28	York	york	NNP	_	26	pobj	_
29	,	,	,	_	15	punct	_
30	noting	note	VBG	pb=note.01	15	advcl	15:AM-ADV
31	that	that	IN	p2=DT	37	complm	_
32	substantial	substantial	JJ	_	33	amod	_
33	stakeholders	stakeholder	NNS	_	37	nsubj	37:A0=PAG
34	on	on	IN	_	33	prep	_
35	both	both	DT	_	36	det	_
36	sides	side	NNS	_	34	pobj	_
37	want	want	VBP	pb=want.01	30	ccomp	30:A1=PPT
38	the	the	DT	_	39	det	_
39	deal	deal	NN	_	41	nsubj	41:A1=PPT
40	to	to	TO	_	41	aux	_
41	happen	happen	VB	pb=happen.01	37	ccomp	37:A1=PPT
42	.	.	.	_	15	punct	_

1	"	"	``	_	17	punct	_
2	If	if	IN	_	5	mark	_
3	Pfizer	pfizer	NNP	_	5	nsubj	5:A0=PAG
4	can	can	MD	_	5	aux	5:AM-MOD
5	tweak	tweak	VB	pb=tweak.01	17	advcl	17:AM-ADV
6	its	its	PRP$	_	7	poss	_
7	bid	bid	NN	_	5	dobj	5:A1=PPT
8	a	a	DT	_	10	det	_
9	little	little	JJ	_	10	amod	_
10	bit	bit	NN	_	11	npadvmod	_
11	more	more	RBR	p2=JJR	5	advmod	5:AM-EXT
12	,	,	,	_	17	punct	_
13	then	then	RB	_	17	advmod	17:AM-TMP
14	AstraZeneca	astrazeneca	NNP	p2=IN	15	nn	_
15	shareholders	shareholder	NNS	_	17	nsubj	17:A0=PAG
16	are	be	VBP	_	17	aux	_
17	getting	get	VBG	pb=get.01	31	ccomp	31:A1=PPT
18	a	a	DT	_	21	det	_
19	very	very	RB	_	20	advmod	_
20	good	good	JJ	_	21	amod	_
21	deal	deal	NN	_	17	dobj	17:A1=PPT
22	,	,	,	_	17	punct	_
23	and	and	CC	_	17	cc	_
24	they	they	PRP	_	26	nsubj	26:A0
25	should	should	MD	_	26	aux	26:AM-MOD
26	take	take	VB	pb=take.01	17	conj	_
27	it	it	PRP	_	26	dobj	26:A1=PPT
28	,	,	,	_	31	punct	_
29	"	"	''	_	31	punct	_
30	Selvaraju	selvaraju	NNP	_	31	nsubj	31:A0
31	said	say	VBD	pb=say.01	0	root	_
32	.	.	.	_	31	punct	_

1	"	"	``	_	3	punct	_
2	They	they	PRP	_	3	nsubj	3:A1=PPT
3	're	be	VBP	pb=be.01	0	root	_
4	really	really	RB	_	3	advmod	3:AM-ADV
5	not	not	RB	_	3	neg	3:AM-NEG
6	that	that	RB	_	7	advmod	_
7	far	far	RB	_	8	advmod	_
8	apart	apart	RB	_	3	advmod	3:A2=PRD
9	as	as	RB	_	10	advmod	_
10	far	far	RB	_	3	advmod	3:AM-ADV
11	as	as	IN	_	14	mark	_
12	I	I	PRP	_	14	nsubj	14:A0=PAG
13	can	can	MD	_	14	aux	14:AM-MOD
14	tell	tell	VB	pb=tell.01	10	advcl	_
15	.	.	.	_	3	punct	_
16	"	"	''	_	3	punct	_

1	When	when	WRB	_	3	advmod	3:R-AM-TMP
2	Pfizer	pfizer	NNP	_	3	nsubj	3:A0=PAG
3	delivered	deliver	VBD	pb=deliver.01	30	advcl	30:AM-TMP
4	its	its	PRP$	_	13	poss	_
5	"	"	``	_	13	punct	_
6	final	final	JJ	_	13	amod	_
7	"	"	''	p2=``	13	punct	_
8	cash	cash	NN	_	13	nn	_
9	-	-	HYPH	p2=,	8	hyph	_
10	and	and	CC	_	8	cc	_
11	-	-	HYPH	_	12	hyph	_
12	stock	stock	NN	_	8	conj	_
13	offer	offer	NN	_	3	dobj	3:A1=PPT
14	of	of	IN	_	13	prep	_
15	55	0	CD	_	16	num	_
16	pounds	pound	NNS	_	14	pobj	_
17	per	per	IN	_	16	prep	_
18	share	share	NN	p2=VB	17	pobj	_
19	-	-	:	p2=HYPH	16	punct	_
20	or	or	CC	_	16	cc	_
21	around	around	IN	p2=RB	23	advmod	_
22	70	0	CD	_	23	number	_
23	billion	#crd#	CD	_	24	num	_
24	pounds	pound	NNS	_	26	hmod	_
25	-	-	HYPH	p2=:	26	hyph	_
26	on	on	RP	p2=IN	27	amod	_
27	Sunday	sunday	NNP	_	3	npadvmod	3:AM-TMP
28	,	,	,	_	30	punct	_
29	it	it	PRP	_	30	nsubj	30:A0
30	said	say	VBD	pb=say.01	0	root	_
31	it	it	PRP	_	33	nsubj	33:A0=PPT;37:A0=PPT
32	would	would	MD	_	33	aux	33:AM-MOD;37:AM-MOD
33	walk	walk	VB	pb=walk.01	30	ccomp	30:A1=PPT
34	away	away	RB	_	33	advmod	33:AM-DIR
35	rather	rather	RB	_	36	advmod	_
36	than	than	IN	_	33	cc	_
37	go	go	VB	pb=go.02	33	conj	_
38	directly	directly	RB	_	37	advmod	37:AM-MNR
39	to	to	IN	_	37	prep	37:A4=GOL
40	shareholders	shareholder	NNS	_	39	pobj	_
41	in	in	IN	_	37	prep	37:AM-PRP
42	a	a	DT	_	45	det	_
43	hostile	hostile	JJ	_	45	amod	_
44	takeover	takeover	NN	_	45	nn	_
45	maneuver	maneuver	NN	_	41	pobj	_
46	.	.	.	_	30	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=DT	2	nn	_
2	management	management	NN	_	4	nsubj	4:A0=CAU
3	had	have	VBD	_	4	aux	_
4	indicated	indicate	VBN	pb=indicate.01	0	root	_
5	any	any	DT	_	6	det	_
6	offer	offer	NN	_	4	dobj	4:A1=PPT
7	below	below	IN	_	6	prep	_
8	58.85	0	CD	_	9	num	_
9	pounds	pound	NNS	_	7	pobj	_
10	per	per	IN	_	9	prep	_
11	share	share	NN	_	10	pobj	_
12	undervalued	undervalue	VBD	p2=VBN|pb=undervalue.01	4	ccomp	_
13	the	the	DT	_	14	det	_
14	company	company	NN	_	12	dobj	12:A1=PPT
15	.	.	.	_	4	punct	_

1	"	"	``	_	3	punct	_
2	It	it	PRP	_	3	nsubj	_
3	seems	seem	VBZ	pb=seem.01	0	root	_
4	like	like	IN	_	6	mark	_
5	Pfizer	pfizer	NNP	_	6	nsubj	6:A1=PPT
6	was	be	VBD	pb=be.01	3	advcl	3:A1=PPT
7	very	very	RB	_	8	advmod	_
8	adamant	adamant	JJ	_	6	acomp	6:A2=PRD
9	about	about	IN	_	8	prep	_
10	wanting	want	VBG	pb=want.01	9	pcomp	_
11	to	to	TO	_	12	aux	_
12	do	do	VB	pb=do.02	10	xcomp	10:A1=PPT
13	the	the	DT	_	14	det	_
14	deal	deal	NN	_	12	dobj	12:A1=PPT
15	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	latest	late	JJS	_	3	amod	_
3	salvo	salvo	NN	_	6	nsubj	6:A0=PAG
4	of	of	IN	_	3	prep	_
5	discussion	discussion	NN	_	4	pobj	_
6	suggests	suggest	VBZ	pb=suggest.01	19	ccomp	19:A1=PPT
7	the	the	DT	_	8	det	_
8	chances	chance	NNS	_	10	nsubj	10:A1=PPT
9	have	have	VBP	_	10	aux	_
10	declined	decline	VBN	pb=decline.01	6	ccomp	6:A1=PPT
11	,	,	,	_	6	punct	_
12	but	but	CC	_	6	cc	_
13	they	they	PRP	_	14	nsubj	14:A1=PPT
14	're	be	VBP	pb=be.01	6	conj	_
15	not	not	RB	_	14	neg	14:AM-NEG
16	zero	#crd#	CD	_	14	attr	14:A2=PRD
17	,	,	,	_	19	punct	_
18	"	"	''	p2=``	19	punct	_
19	said	say	VBD	pb=say.01	0	root	_
20	Les	les	NNP	_	21	nn	_
21	Funtleyder	funtleyder	NNP	_	19	nsubj	19:A0
22	,	,	,	_	21	punct	_
23	author	author	NN	_	21	appos	_
24	of	of	IN	_	23	prep	_
25	"	"	``	_	27	punct	_
26	Healthcare	healthcare	NNP	_	27	nn	_
27	Investing	invest	VBG	p2=NNP	24	pobj	_
28	"	"	''	_	27	punct	_
29	and	and	CC	_	23	cc	_
30	a	a	DT	_	32	det	_
31	consulting	consulting	NN	p2=VBG	32	nn	_
32	partner	partner	NN	_	23	conj	_
33	in	in	IN	_	32	prep	_
34	U.K	u.k	NNP	_	33	pobj	_
35	.	.	.	_	19	punct	_

1	-	-	HYPH	p2=:	2	hyph	_
2	based	base	VBN	_	6	amod	_
3	Bluecloud	bluecloud	NNP	_	4	nn	_
4	Healthcare	healthcare	NNP	_	6	nn	_
5	consulting	consulting	NN	p2=VBG	6	nn	_
6	firm	firm	NN	_	0	root	_
7	.	.	.	_	6	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nn	_
2	spokeswoman	spokeswoman	NN	_	4	nn	_
3	Joan	joan	NNP	_	4	nn	_
4	Campion	campion	NNP	_	5	nsubj	5:A0
5	said	say	VBD	pb=say.01	0	root	_
6	in	in	IN	_	5	prep	5:AM-LOC
7	an	an	DT	_	9	det	_
8	emailed	emailed	JJ	p2=VBN	9	amod	_
9	statement	statement	NN	_	6	pobj	_
10	:	:	:	_	5	punct	_
11	"	"	``	_	5	punct	_
12	The	the	DT	_	13	det	_
13	fate	fate	NN	_	17	nsubj	17:A1=PPT
14	of	of	IN	_	13	prep	_
15	the	the	DT	_	16	det	_
16	deal	deal	NN	_	14	pobj	_
17	is	be	VBZ	pb=be.01	5	ccomp	5:A1=PPT
18	now	now	RB	_	17	advmod	17:AM-TMP
19	up	up	IN	p2=RB	17	prep	17:A2=PRD
20	to	to	IN	_	19	prep	_
21	AstraZeneca	astrazeneca	NNP	_	23	poss	_
22	's	's	POS	_	21	possessive	_
23	shareholders	shareholder	NNS	_	20	pobj	_
24	.	.	.	_	5	punct	_

1	We	we	PRP	_	2	nsubj	2:A0=PAG
2	believe	believe	VBP	pb=believe.01	0	root	_
3	our	our	PRP$	_	5	poss	_
4	final	final	JJ	_	5	amod	_
5	proposal	proposal	NN	_	6	nsubj	6:A0=PAG
6	represents	represent	VBZ	pb=represent.01	2	ccomp	2:A1=PPT
7	compelling	compelling	JJ	_	10	amod	_
8	and	and	CC	_	7	cc	_
9	full	full	JJ	_	7	conj	_
10	value	value	NN	_	6	dobj	6:A1=PPT
11	for	for	IN	_	10	prep	_
12	AstraZeneca	astrazeneca	NNP	_	13	nn	_
13	shareholders	shareholder	NNS	_	11	pobj	_
14	.	.	.	_	2	punct	_
15	"	"	''	_	2	punct	_

1	If	if	IN	_	4	mark	_
2	the	the	DT	_	3	det	_
3	deal	deal	NN	_	4	nsubj	4:A1=PPT
4	goes	go	VBZ	pb=go.20	9	advcl	9:AM-ADV
5	through	through	RB	p2=RP	4	prt	4:C-V
6	,	,	,	_	9	punct	_
7	it	it	PRP	_	9	nsubj	9:A0=PAG
8	would	would	MD	_	9	aux	9:AM-MOD
9	create	create	VB	pb=create.01	0	root	_
10	the	the	DT	_	11	det	_
11	world	world	NN	_	14	poss	_
12	's	's	POS	_	11	possessive	_
13	largest	large	JJS	_	14	amod	_
14	drugmaker	drugmaker	NN	_	9	dobj	9:A1=PPT
15	.	.	.	_	9	punct	_

1	One	#crd#	CD	_	12	nsubj	12:A1=PPT
2	of	of	IN	_	1	prep	_
3	the	the	DT	_	5	det	_
4	primary	primary	JJ	_	5	amod	_
5	reasons	reason	NNS	_	2	pobj	6:A0=PAG
6	driving	drive	VBG	pb=drive.02	5	partmod	_
7	Pfizer	pfizer	NNP	_	9	poss	_
8	's	's	POS	_	7	possessive	_
9	bid	bid	NN	_	6	dobj	6:A1=PPT
10	for	for	IN	_	9	prep	_
11	AstraZeneca	astrazeneca	NNP	_	10	pobj	_
12	is	be	VBZ	pb=be.01	0	root	_
13	the	the	DT	_	14	det	_
14	UK	uk	NNP	_	20	poss	_
15	's	's	POS	p2=VBZ	14	possessive	_
16	significantly	significantly	RB	_	17	advmod	_
17	lower	low	JJR	p2=RBR	20	amod	_
18	corporate	corporate	JJ	_	20	amod	_
19	tax	tax	NN	_	20	nn	_
20	rate	rate	NN	_	12	attr	25:A1;12:A2=PRD
21	,	,	,	_	20	punct	_
22	which	which	WDT	_	27	pobj	_
23	Pfizer	pfizer	NNP	p2=NN	25	nsubj	25:A0
24	could	could	MD	_	25	aux	25:AM-MOD
25	take	take	VB	pb=take.01	20	rcmod	_
26	advantage	advantage	NN	_	25	dobj	25:A1=PPT
27	of	of	IN	_	25	prep	25:R-A2=DIR
28	if	if	IN	_	31	mark	_
29	it	it	PRP	_	31	nsubjpass	33:A0;31:A1=PPT
30	were	be	VBD	_	31	auxpass	_
31	allowed	allow	VBN	pb=allow.01	25	advcl	25:AM-ADV
32	to	to	TO	p2=IN	33	aux	_
33	redomicile	redomicile	VB	pb=redomicile.01	31	xcomp	31:C-A1
34	in	in	IN	p2=RP	33	prep	33:AM-LOC
35	Britain	britain	NNP	_	34	pobj	_
36	.	.	.	_	12	punct	_

1	Those	those	DT	_	2	det	_
2	kinds	kind	NNS	_	7	nsubj	7:A1=PPT
3	of	of	IN	_	2	prep	_
4	savings	saving	NNS	_	3	pobj	_
5	would	would	MD	_	7	aux	7:AM-MOD
6	not	not	RB	_	7	neg	7:AM-NEG
7	be	be	VB	pb=be.01	0	root	_
8	available	available	JJ	_	7	acomp	7:A2=PRD
9	if	if	IN	_	11	mark	_
10	it	it	PRP	_	11	nsubj	11:A0=PAG
11	chose	choose	VBD	pb=choose.01	7	advcl	7:AM-ADV
12	another	another	DT	_	14	det	_
13	takeover	takeover	NN	_	14	nn	_
14	target	target	NN	_	11	dobj	11:A1=PPT
15	.	.	.	_	7	punct	_

1	Len	len	NNP	_	2	nn	_
2	Yaffe	yaffe	NNP	_	20	nsubj	20:A0
3	,	,	,	_	2	punct	_
4	portfolio	portfolio	NN	_	5	nn	_
5	manager	manager	NN	_	2	appos	_
6	of	of	IN	_	5	prep	_
7	the	the	DT	_	13	det	_
8	San	san	NNP	_	9	nn	_
9	Francisco-based	francisco-based	NNP	p2=JJ	11	nn	_
10	healthcare	healthcare	NN	_	11	nn	_
11	fund	fund	NN	_	13	nn	_
12	StockDoc	stockdoc	NNP	_	13	nn	_
13	Partners	partner	NNPS	p2=NNP	6	pobj	16:A0=PAG
14	,	,	,	_	13	punct	_
15	which	which	WDT	_	16	nsubj	16:R-A0
16	has	have	VBZ	pb=have.03	13	rcmod	_
17	Pfizer	pfizer	NNP	_	18	nn	_
18	holdings	holding	NNS	_	16	dobj	16:A1=PPT
19	,	,	,	_	2	punct	_
20	said	say	VBD	pb=say.01	0	root	_
21	he	he	PRP	_	22	nsubj	22:A0=PAG
22	believes	believe	VBZ	pb=believe.01	20	ccomp	20:A1=PPT
23	Pfizer	pfizer	NNP	_	25	nsubj	25:A0=PPT;27:A0=PAG
24	should	should	MD	_	25	aux	25:AM-MOD
25	focus	focus	VB	pb=focus.01	22	ccomp	22:A1=PPT
26	on	on	IN	_	25	prep	25:A2=PPT
27	building	build	VBG	pb=build.01	26	pcomp	_
28	its	its	PRP$	_	29	poss	_
29	pipeline	pipeline	NN	_	27	dobj	27:A1=PRD
30	of	of	IN	_	29	prep	_
31	drugs	drug	NNS	_	30	pobj	_
32	in	in	IN	_	31	prep	_
33	development	development	NN	_	32	pobj	_
34	rather	rather	RB	_	35	advmod	_
35	than	than	IN	_	33	cc	_
36	tax	tax	NN	p2=VB	37	nn	_
37	engineering	engineering	NN	_	33	conj	_
38	.	.	.	_	20	punct	_

1	"	"	``	p2=''	16	punct	_
2	Where	where	WRB	_	5	advmod	5:R-AM-LOC
3	they	they	PRP	_	5	nsubj	5:A0=PAG
4	would	would	MD	_	5	aux	5:AM-MOD
5	get	get	VB	pb=get.01	16	advcl	_
6	a	a	DT	_	8	det	_
7	better	good	JJR	_	8	amod	_
8	return	return	NN	_	5	dobj	5:A1=PPT
9	in	in	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	long	long	JJ	_	12	amod	_
12	term	term	NN	_	9	pobj	_
13	,	,	,	_	16	punct	_
14	it	it	PRP	_	16	nsubj	16:A0=PAG
15	would	would	MD	_	16	aux	16:AM-MOD
16	make	make	VB	pb=make.01	25	ccomp	25:A1=PPT
17	sense	sense	NN	_	16	dobj	16:A1=PRD
18	for	for	IN	_	21	mark	_
19	them	them	PRP	_	21	nsubj	21:A0=PAG
20	to	to	TO	_	21	aux	_
21	buy	buy	VB	pb=buy.01	16	advcl	16:A2=VSP
22	,	,	,	_	25	punct	_
23	"	"	''	p2=``	25	punct	_
24	Yaffe	yaffe	NNP	_	25	nsubj	25:A0;27:A0=PAG
25	said	say	VBD	pb=say.01	0	root	_
26	,	,	,	_	25	punct	_
27	citing	cite	VBG	pb=cite.01	25	advcl	25:AM-ADV
28	large	large	JJ	_	30	amod	_
29	biotech	biotech	JJ	p2=NN	30	amod	_
30	companies	company	NNS	_	27	dobj	27:A1=PPT
31	such	such	JJ	_	32	amod	_
32	as	as	IN	_	30	prep	_
33	Regeneron	regeneron	NNP	_	34	nn	_
34	Pharmaceuticals	pharmaceuticals	NNP	p2=NNPS	32	pobj	_
35	(	(	-LRB-	_	34	punct	_
36	REGN.O	regn.o	NNP	_	34	appos	_
37	)	)	-RRB-	_	34	punct	_
38	,	,	,	_	34	punct	_
39	Gilead	gilead	NNP	_	40	nn	_
40	Sciences	science	NNPS	p2=NNP	34	conj	_
41	(	(	-LRB-	_	44	punct	_
42	GILD.O	gild.o	NNP	p2=NN	44	nn	_
43	)	)	-RRB-	_	44	punct	_
44	Celgene	celgene	NNP	_	40	conj	_
45	(	(	-LRB-	_	44	punct	_
46	CELG.O	celg.o	NNP	_	44	appos	_
47	)	)	-RRB-	_	44	punct	_
48	and	and	CC	_	44	cc	_
49	Biogen	biogen	NNP	_	50	nn	_
50	Idec	idec	NNP	_	44	conj	_
51	(	(	-LRB-	_	52	punct	_
52	BIIB.O	biib.o	NNP	_	50	appos	_
53	)	)	-RRB-	_	52	punct	_
54	,	,	,	_	50	punct	_
55	whose	whose	WP$	_	58	poss	_
56	promising	promising	JJ	p2=VBG	58	amod	_
57	new	new	JJ	_	58	amod	_
58	drugs	drug	NNS	_	60	nsubj	60:R-A0
59	have	have	VBP	_	60	aux	_
60	lifted	lift	VBN	pb=lift.02	30	rcmod	_
61	their	their	PRP$	_	63	poss	_
62	stock	stock	NN	_	63	nn	_
63	prices	price	NNS	_	60	dobj	60:A1=PPT
64	.	.	.	_	25	punct	_

1	Pfizer	pfizer	NNP	_	4	nn	_
2	Chief	chief	NNP	_	4	nn	_
3	Executive	executive	NNP	_	4	nn	_
4	Officer	officer	NNP	_	6	nn	_
5	Ian	ian	NNP	_	6	nn	_
6	Read	read	NNP	_	8	nsubj	8:A0=PAG
7	has	have	VBZ	_	8	aux	_
8	signaled	signal	VBN	pb=signal.01	0	root	_
9	the	the	DT	_	10	det	_
10	company	company	NN	_	13	nsubj	13:A0=PAG
11	wo	wo	MD	_	13	aux	13:AM-MOD
12	n't	not	RB	_	13	neg	13:AM-NEG
13	consider	consider	VB	pb=consider.01	8	ccomp	8:A1=PPT
14	large	large	JJ	_	17	amod	_
15	U.S.	u.s.	NNP	_	17	nn	_
16	drugmaker	drugmaker	NN	p2=NNP	17	nn	_
17	acquisitions	acquisition	NNS	_	13	dobj	13:A1
18	,	,	,	_	13	punct	_
19	given	give	VBN	_	13	prep	_
20	the	the	DT	_	24	det	_
21	comparatively	comparatively	RB	p2=JJ	22	advmod	_
22	high	high	JJ	_	24	amod	_
23	tax	tax	NN	_	24	nn	_
24	rates	rate	NNS	_	19	pobj	_
25	.	.	.	_	8	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=NN	4	nsubj	4:A0=PAG
2	has	have	VBZ	_	4	aux	_
3	been	be	VBN	_	4	aux	_
4	promoting	promote	VBG	pb=promote.02	0	root	_
5	its	its	PRP$	_	7	poss	_
6	own	own	JJ	_	7	amod	_
7	pipeline	pipeline	NN	_	4	dobj	4:A1=PPT
8	,	,	,	_	7	punct	_
9	especially	especially	RB	_	13	advmod	_
10	its	its	PRP$	_	13	poss	_
11	cancer	cancer	NN	_	12	nn	_
12	immunotherapy	immunotherapy	NN	p2=IN	13	nn	_
13	drugs	drug	NNS	_	7	appos	_
14	,	,	,	_	7	punct	_
15	in	in	IN	_	4	prep	_
16	making	make	VBG	pb=make.01	15	pcomp	_
17	the	the	DT	_	18	det	_
18	case	case	NN	_	16	dobj	16:A1=PRD
19	that	that	IN	p2=WDT	22	complm	_
20	Pfizer	pfizer	NNP	_	22	nsubj	22:A0=PAG
21	has	have	VBZ	_	22	aux	_
22	undervalued	undervalue	VBN	pb=undervalue.01	18	ccomp	_
23	the	the	DT	_	24	det	_
24	company	company	NN	_	22	dobj	22:A1=PPT
25	.	.	.	_	4	punct	_

1	CEO	ceo	NN	p2=NNP	5	nn	_
2	Pascal	pascal	NNP	_	3	nn	_
3	Soriot	soriot	NNP	p2=VBD	5	nn	_
4	forecast	forecast	NN	p2=VBD	5	nn	_
5	revenue	revenue	NN	_	6	nsubj	6:A1=PPT
6	growing	grow	VBG	pb=grow.01	0	root	_
7	above	above	IN	_	6	prep	6:A4=PRD
8	$	$	$	_	10	quantmod	_
9	45	0	CD	_	10	number	_
10	billion	#crd#	CD	_	7	pobj	_
11	by	by	IN	_	10	prep	_
12	2023	0	CD	_	11	pobj	_
13	.	.	.	_	6	punct	_

1	"	"	``	p2=''	5	punct	_
2	Pascal	pascal	NNP	_	3	nn	_
3	Soriot	soriot	NNP	p2=NN	5	nsubj	5:A0
4	can	can	MD	_	5	aux	5:AM-MOD
5	say	say	VB	pb=say.01	0	root	_
6	whatever	whatever	WDT	p2=WP	8	dobj	8:R-A1
7	he	he	PRP	_	8	nsubj	8:A0=PAG
8	wants	want	VBZ	pb=want.01	5	ccomp	5:A1=PPT
9	about	about	IN	_	8	prep	_
10	projections	projection	NNS	_	9	pobj	12:A1=PPT
11	that	that	WDT	_	12	nsubj	12:R-A1
12	go	go	VBP	pb=go.01	10	rcmod	_
13	out	out	RP	p2=IN	12	prt	12:C-V
14	10	0	CD	_	15	num	_
15	years	year	NNS	_	12	npadvmod	12:AM-TMP
16	.	.	.	_	5	punct	_

1	The	the	DT	_	3	det	_
2	only	only	JJ	_	3	amod	_
3	thing	thing	NN	_	9	nsubj	5:A1=PPT;9:A1=PPT
4	we	we	PRP	_	5	nsubj	5:A0=PAG
5	know	know	VBP	pb=know.01	3	rcmod	_
6	about	about	IN	_	5	prep	_
7	such	such	JJ	_	8	amod	_
8	projections	projection	NNS	_	6	pobj	_
9	is	be	VBZ	pb=be.01	18	ccomp	18:A1=PPT
10	that	that	IN	_	13	complm	_
11	they	they	PRP	_	13	nsubj	13:A1=PPT
12	will	will	MD	_	13	aux	13:AM-MOD
13	be	be	VB	pb=be.01	9	ccomp	9:A2=PRD
14	wrong	wrong	JJ	_	13	acomp	13:A2=PRD
15	,	,	,	p2=.	18	punct	_
16	"	"	''	_	18	punct	_
17	Selvaraju	selvaraju	NNP	p2=NN	18	nsubj	18:A0
18	said	say	VBD	pb=say.01	0	root	_
19	.	.	.	_	18	punct	_

1	For	for	IN	_	16	prep	16:AM-GOL
2	tax	tax	NN	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	inversion	inversion	NN	_	5	nn	_
5	purposes	purpose	NNS	_	1	pobj	_
6	,	,	,	_	16	punct	_
7	GlaxoSmithKline	glaxosmithkline	NNP	p2=VB	16	nsubj	16:A1=PPT
8	with	with	IN	_	7	prep	_
9	a	a	DT	_	11	det	_
10	market	market	NN	_	11	nn	_
11	cap	cap	NN	_	8	pobj	_
12	of	of	IN	_	11	prep	_
13	$	$	$	_	15	quantmod	_
14	132	0	CD	_	15	number	_
15	billion	#crd#	CD	_	12	pobj	_
16	was	be	VBD	pb=be.01	0	root	_
17	the	the	DT	_	20	det	_
18	only	only	JJ	p2=RB	20	amod	_
19	comparable	comparable	JJ	_	20	amod	_
20	target	target	NN	_	16	attr	16:A2=PRD
21	,	,	,	_	16	punct	_
22	according	accord	VBG	_	16	prep	16:AM-ADV
23	to	to	IN	_	22	prep	_
24	Selvaraju	selvaraju	NNP	p2=NN	23	pobj	_
25	.	.	.	_	16	punct	_

1	"	"	``	_	13	punct	_
2	GlaxoSmithKline	glaxosmithkline	NNP	p2=NN	3	nsubj	3:A1=PPT
3	is	be	VBZ	pb=be.01	13	ccomp	13:A1=PPT
4	nowhere	nowhere	RB	_	3	advmod	_
5	near	near	RB	p2=IN	7	advmod	_
6	as	as	RB	_	7	advmod	_
7	weak	weak	JJ	_	3	acomp	3:A2=PRD
8	as	as	IN	_	7	prep	_
9	AstraZeneca	astrazeneca	NNP	_	8	pobj	_
10	,	,	,	_	13	punct	_
11	"	"	''	p2=``	13	punct	_
12	he	he	PRP	_	13	nsubj	13:A0
13	said	say	VBD	pb=say.01	0	root	_
14	.	.	.	_	13	punct	_

1	"	"	``	_	4	punct	_
2	It	it	PRP	_	4	nsubj	6:A1=PPT
3	almost	almost	RB	_	4	advmod	_
4	has	have	VBZ	pb=have.02	0	root	_
5	to	to	TO	_	6	aux	_
6	be	be	VB	pb=be.01	4	xcomp	_
7	(	(	-LRB-	_	6	punct	_
8	AstraZeneca	astrazeneca	NNP	_	6	npadvmod	6:A2=PRD
9	)	)	-RRB-	_	6	punct	_
10	or	or	CC	_	4	cc	_
11	Pfizer	pfizer	NNP	_	12	nsubj	15:A0=PAG;12:A1=PPT
12	goes	go	VBZ	pb=go.01	4	conj	_
13	back	back	RB	_	12	advmod	12:A4=GOL
14	to	to	IN	_	13	prep	_
15	playing	play	VBG	p2=NN|pb=play.01	14	pcomp	_
16	the	the	DT	_	18	det	_
17	waiting	wait	VBG	p2=NN	18	nn	_
18	game	game	NN	_	15	dobj	15:A1=PPT
19	.	.	.	_	12	punct	_
20	"	"	''	_	12	punct	_

